EVIO, Inc. (OTCQB: EVIO), a leading provider of cannabis analytical testing services, this morning announced that its EVIO Labs division has already exceeded last October’s testing revenues through the first half of October 2017, with sales surpassing $250,000. “Our national sales team continues to expand EVIO’s service offerings,” William Waldrop, CEO of EVIO, stated in the news release. “After an impressive 2017, in which we exceeded our own internal projections, we are starting the 2018 fiscal year on the right track. We are eagerly waiting for the upcoming accreditation of our new pesticide equipment. As mentioned in our 8K, the Oregon Environmental Laboratory Accreditation Program (ORELAP) has provided Monday, October 23, 2017 as their on-site assessment date. As soon [as] our accreditation scope is expanded to include full-service pesticides, the company will be able to perform a majority of our testing in-house. This will tremendously improve our gross margins and overall profitability.”
Read the full article
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
EVIO, Inc. (EVIO) Announces Strong Start to Fiscal 2018
